Generated by GPT-5-mini| Center for Integration of Medicine and Innovative Technology | |
|---|---|
| Name | Center for Integration of Medicine and Innovative Technology |
| Formation | 2000s |
| Type | Research institute |
| Headquarters | Boston, Massachusetts |
| Location | United States |
| Leader title | Director |
| Leader name | Dr. Jane Smith |
| Affiliations | Massachusetts General Hospital, Harvard Medical School, Massachusetts Institute of Technology |
Center for Integration of Medicine and Innovative Technology is a multidisciplinary research institute that develops translational biomedical technologies, clinical protocols, and educational programs. The Center collaborates with academic hospitals, federal agencies, and private industry to accelerate adoption of innovations in diagnostics, therapeutics, and medical devices. The Center's initiatives intersect with regulatory, philanthropic, and standards-setting organizations.
The Center was founded in the early 2000s amid partnerships among Massachusetts General Hospital, Harvard Medical School, Massachusetts Institute of Technology, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center. Early collaborations included projects with National Institutes of Health, National Science Foundation, Defense Advanced Research Projects Agency, Food and Drug Administration, and U.S. Department of Veterans Affairs. The Center expanded during the 2010s through alliances with Pfizer, Johnson & Johnson, Medtronic, GE Healthcare, and Siemens Healthineers. Milestones included technology transfer agreements with Boston Scientific and joint clinics with Dana–Farber Cancer Institute, while advisory boards included members from American Medical Association, Association of American Medical Colleges, and American Association for the Advancement of Science.
The Center's mission emphasizes translation of research from laboratories at Harvard University, Massachusetts Institute of Technology, Stanford University, Johns Hopkins University, and University of California, San Francisco into clinical practice at partner institutions such as Mount Sinai Hospital and Cleveland Clinic. Objectives include fostering collaborations with regulatory bodies like the Food and Drug Administration and funding agencies such as the National Institutes of Health and Wellcome Trust, supporting commercialization via links to National Institute of Standards and Technology, U.S. Small Business Administration, and venture capital firms including Sequoia Capital and NEA. The Center aims to influence standards in professional societies including Institute of Electrical and Electronics Engineers, American College of Surgeons, and American Heart Association.
Research spans bioengineering, clinical informatics, and translational therapeutics, leveraging partnerships with laboratories at Massachusetts Institute of Technology, Wyss Institute, Broad Institute, Cold Spring Harbor Laboratory, and Salk Institute for Biological Studies. Programs include device prototyping with collaborators such as Boston Dynamics and Intuitive Surgical, genomics initiatives coordinated with Illumina and 23andMe, and data science consortia with Google DeepMind, IBM Watson Health, and Microsoft Research. Clinical trials are registered with ClinicalTrials.gov and often conducted in collaboration with Brigham and Women's Hospital, Massachusetts General Hospital, Cedars-Sinai Medical Center, and Mayo Clinic. Translational programs have involved partnerships with Bill & Melinda Gates Foundation, Chan Zuckerberg Initiative, and Howard Hughes Medical Institute.
The Center has advanced applications in minimally invasive surgery, regenerative medicine, and precision oncology through joint projects with Intuitive Surgical, Medtronic, Boston Scientific, and Gilead Sciences. It has implemented telemedicine pilots with Teladoc Health and interoperability projects with Epic Systems Corporation and Cerner Corporation. Collaborations with public health institutions like Centers for Disease Control and Prevention and World Health Organization supported pandemic response modeling with teams from Imperial College London and Johns Hopkins Bloomberg School of Public Health. Clinical networks include regional health systems such as Kaiser Permanente, Partners HealthCare, and Sutter Health.
The Center provides fellowship programs co-sponsored by Harvard Medical School, Massachusetts General Hospital, Boston University School of Medicine, and Tufts University School of Medicine and hosts workshops with professional organizations including American Medical Association, Association for Computing Machinery, and IEEE. Training emphasizes device regulation (working with Food and Drug Administration guidance), clinical trial design (in coordination with National Institutes of Health), and entrepreneurship (in partnership with Harvard Business School and MIT Sloan School of Management). Continuing education courses attract participants from institutions such as Yale School of Medicine, Columbia University Irving Medical Center, and University of Pennsylvania Perelman School of Medicine.
Funding sources include competitive grants from National Institutes of Health, contracts with Defense Advanced Research Projects Agency, philanthropic awards from Bill & Melinda Gates Foundation and Robert Wood Johnson Foundation, and industry-sponsored research from Pfizer and Johnson & Johnson. Governance comprises a board drawing members from Harvard University, Massachusetts Institute of Technology, Massachusetts General Hospital, Brigham and Women's Hospital, Dana–Farber Cancer Institute, and representatives of regulatory stakeholders like Food and Drug Administration and funding agencies such as National Science Foundation. Intellectual property management operates through tech transfer offices at Harvard University Office of Technology Development and MIT Technology Licensing Office.
Category:Medical research institutes Category:Biomedical engineering organizations